Free shipping on all orders over $ 500

Aminooxy-acetic acid (AOA) hemihydrochloride

Cat. No. M8879

All AbMole products are for research use only, cannot be used for human consumption.

Aminooxy-acetic acid (AOA) hemihydrochloride Structure
Synonym:

Carboxymethoxylamine Hemihydrochloride

Size Price Availability Quantity
500mg USD 40  USD40 In stock
1g USD 60  USD60 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Aminooxyacetic acid hemihydrochloride is a malate-aspartate shuttle (MAS) inhibitor which also inhibits the GABA degradating enzyme GABA-T. AOA hemihydrochloride dose-dependently decreases the survival of C6 glioma cells. Aminooxyacetic acid hemihydrochloride treatment produces a significant increase in the percentage of the cells arrested in the stage of G0/G1, as well as a significant decrease in the percentage of the cells at S phase and G2/M phase.

The accumulation of GABA in cerebellum and whole brain is initially very rapid, being significantly increased already 5 min after the injection of Aminooxyacetic acid hemihydrochloride (AOAA). The rapid initial accumulation becomes gradually slower and maximal levels (400 to 600 % of the control levels) are reached 2 to 6 h after Aminooxyacetic acid hemihydrochloride. Still 24 h after Aminooxyacetic acid hemihydrochloride the GABA levels are elevated by about 250%.

Chemical Information
Molecular Weight 109.3
Formula NH2OCH2COOH · 0.5HCl
CAS Number 2921-14-4
Solubility (25°C) DMSO 100 mg/mL
Water 90 mg/mL
Storage 4°C, protect from light, dry, sealed
References

[1] Wang C, et al. Cancer Lett. Malate-aspartate shuttle inhibitor aminooxyacetic acid leads to decreased intracellular ATP levels and altered cell cycle of C6 glioma cells by inhibiting glycolysis.

[2] Korangath P, et al. Clin Cancer Res. Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate.

Related GABA Receptor Products
β-CCB 

β-CCB is a ligand for benzodiazepine receptor, which inhibits the binding of [3H]flunitrazepam and ethyl (3-[3H]carboline-3-carboxylate to benzodiazepine receptors, with Ki of 3-4 nM.

TPMPA 

TPMPA, a hybrid of isoguvacine and 3-APMPA, is the first selective antagonist for a GABAC receptor (KB = 2.1 μM), but not to interact with GABAA (KB = 320 μM) or GABAB receptors (EC50 = 500 μM).

CI-966 

CI-966 is a potent, selective, orally active and brain-penetrant inhibitor of the GABA transporter GAT-1, with IC50s of 0.26 μM and 1.2 μM for hGAT-1, rGAT-1, respectively.

NCS-382 

NCS-382 is a potent GABA receptor antagonist and also a GHBR receptor antagonist.

CGS 8216 

CGS 8216, a benzodiazepine receptor antagonist, inhibits 3H-flunitrazepam (3H-FLU) binding to rat synaptosomal membranes in vitro at subnanomolar concentrations.

  Catalog
Abmole Inhibitor Catalog




Keywords: Aminooxy-acetic acid (AOA) hemihydrochloride, Carboxymethoxylamine Hemihydrochloride supplier, GABA Receptor, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.